Key result
Adjuvant chemoradiotherapy after surgery fails to improve OS or RFS in dedifferentiated liposarcoma.
Why the study?
The study was conducted to report 2 cases of dedifferentiated liposarcoma in the peripharyngeal space and review the literature to summarize clinical and histopathologic features, operative selection, and prognosis.
Does adjuvant chemoradiotherapy improve overall survival or recurrence-free survival in patients with dedifferentiated liposarcoma of the head and neck compared to surgery alone?
Systematic Review (n=60)
Yes
Does adjuvant chemoradiotherapy improve overall survival or recurrence-free survival in patients with dedifferentiated liposarcoma of the head and neck compared to surgery alone?
p-value: p=>0.05
Local radical excision is the preferred treatment for dedifferentiated liposarcoma of the head and neck, with adjuvant chemoradiotherapy showing no significant impact on survival outcomes.
Summarizes features of rare peripharyngeal DDLPS across 60 cases; extends sparse literature but leaves optimal management open.
Purpose: The aim of this study was to report 2 cases of dedifferentiated liposarcoma (DDLPS) in the peripharyngeal space and review the relevant literature to summarize its clinical and histopathologic features and therapeutic approaches, especially operative selection and prognosis. Methods: A comprehensive review of the literature was performed in January 2025 to identify relevant articles using the PubMed database. Sixty patients were included in this study: 2 new cases from Beijing Tongren Hospital in 2018 and 2023, and 58 previously reported cases that occurred between 1979 and 2024 from a systematic review of the literature. We analyzed and summarized the patients’ epidemiological data, clinical features, and treatment regimens. The main outcomes were overall survival (OS) and recurrence-free survival (RFS). Results: DDLPS was approximately twice as common in men as in women, with a median age of 61 years (range: 20–86 y). MDM2 amplification was positive in 13 patients (13/14, 92.9%). Nearly all the patients underwent surgical excision (35/36, 97.2%). Almost half of the patients (17/36, 47.2%) underwent surgery with postoperative radiotherapy (RT). The 1-year, 3-year, and 5-year OS rates were 91.3%, 81.2%, and 81.2%, respectively. The 1-year, 3-year, and 5-year RFS rates were 91.3%, 74.9%, and 64.2%, respectively. Local radical excision is the preferred treatment modality for DDLPS. Adjuvant chemoradiotherapy after radical surgery resection had no statistically significant impact on OS or RFS ( P ˃0.05). Conclusions: Detection of MDM2 during initial biopsy can prevent delays in diagnosis and treatment. Local radical excision is the preferred treatment modality for DDLPS.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a systematic review in Dedifferentiated liposarcoma (DDLPS) in the peripharyngeal space (n=60). Adjuvant chemoradiotherapy after radical surgery resection vs. Radical surgery resection alone was evaluated on Overall survival (OS) and recurrence-free survival (RFS) (p=>0.05). Adjuvant chemoradiotherapy after radical surgery resection had no statistically significant impact on overall survival or recurrence-free survival for dedifferentiated liposarcoma (P>0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: